Test of the Efficacy and Safety of Insulin Glulisine Injected Subcutaneously in Patients With Type 1 Diabetes Mellitus

NCT00964574 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: INSULIN GLULISINE (HMR1964)
DRUG: INSULIN GLARGINE

Sponsor

Sanofi